| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d452df61db54c84de00619a0f4fbe985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa249340db42f42f504e08e6fb70c442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71499ee5cbc2e0ef0934e4f106318743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_094e24e73146c7c40113557c1a4658aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11d75bd5200b00c3938bc5a95e5f0d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd52c37061995c37bf295fe139e5fe16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8434b61041b707e1e73f03acad946297 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccd53624cacb2bc275ce2a8766aba79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8fe10f314ad91f418d9766349ff7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3683bebadc66197d997a2ef8ddd08318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6abebc20258701669d33601f894dcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a7d0417379c74da537e5334cd7779c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992523f8276df4253227010210bb9864 |
| publicationDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009102886-A1 |
| titleOfInvention |
Use of ranolazine for the treatment of cardiovascular diseases |
| abstract |
Disclosed is a method for reducing arrhythmias associated with coronary intervention in a patient comprising administering a pharmaceutical composition comprising ranolazine prior to the coronary intervention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010028173-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8822473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010028173-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883750-B2 |
| priorityDate |
2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |